Bioequivalence testing data to be submitted in product license

Published: 2008-02-05 06:59:00

Updated: 2008-02-05 06:59:00

Drug makers, who intend to apply for the product license for three medicines, will have to submit the bioequivalence data to the Korea Food and Drug Administration (KFDA). The KFDA said the notification is designed to prevent excessive number of me-too products.

The three medicines include aml...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK